Topical Timolol Eye Drops vs Intense Pulsed Light for Post-Acne Erythema

Post-inflammatory erythema (PIE) is a common condition that can occur after acne vulgaris, causing red marks on the skin due to widened blood vessels. While current treatments like intense pulsed light (IPL) can help, they can be expensive and need special equipment. This study focuses on a different approach, using a medication called Timolol, a non-selective beta-adrenergic receptor blocker. Timolol has been shown to narrow blood vessels and has been used in dermatology for conditions related to blood vessels. The goal of this study is to evaluate the effectiveness and safety of a 0.5% Timolol eye drop solution in improving redness left by acne and to compare it with intense pulsed light (IPL) therapy. This research could provide evidence for a more cost-effective and accessible treatment option for managing redness after acne. During this study, participants will use either the Timolol eye drops or undergo IPL therapy. The changes in the severity of redness will be assessed using standard clinical evaluation and objective measurement tools over a specified treatment period. The severity of redness will be measured using the Clinician Erythema Assessment (CEA) scale, which ranges from 0 (clear) to 4 (severe redness). Additionally, the number of red marks on the face will be counted by a dermatologist during clinical examinations.